Abattis Bioceuticals Corp  

(Public, CNSX:ATT)   Watch this stock  
Find more results for cnsx:flu

Officers and directors

Mike Withrow
President, Chief Executive Officer, Director
Rene David
Chief Financial Officer, Chief Operating Officer
Terence Fealey Ph.D.
Independent Director
Douglas J. Sorocco
Independent Director

Address

SUITE 1000 - 355 BURRARD STREET
VANCOUVER, BC V6C 2G8
Canada
+1-604-5386650 (Phone)
+1-604-8881519 (Fax)

Website links

Abattis Bioceuticals Corp, formerly Abattis Biologix Corporation, is a Canada-based company. On April 16, 2009, the Company entered into an agreement with PRB Pharmaceuticals, Inc. (PRB) and Pacific Bio-Pharmaceuticals, Inc. (Pacific Bio) for the purchase of their interest in patents and intellectual property related to anti viral products, which are designed to prevent avian influenza in humans and poultry. As of August 30, 2009, the Company was in the early stage of development and had conducted no active business. It also had not received any revenues other than interest revenues. On March 16, 2012, the Company acquired Animo Wellness Corporation. Effective March 1, 2013, the Company acquired Biocell Labs Inc and Abattis acquired BioExtracts Inc. Effective April 7, 2014, Abattis Bioceuticals Corp acquired 51% interest in Phytalytics LLC.

Related companies

* Delayed by up to 20 minutes -  Disclaimer